Norbert Vey

27PUBLICATIONS
156CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|Jun 06, 2025
Dasatinib overcomes AML cells resistant to BCL2 inhibition by degrading MCL1.

Sylvain Garciaz, Camille Montersino, Maxence Bourgoin

|Mar 15, 2025
Venetoclax-Azacitidine Versus Azacitidine for the Treatment of Primary Refractory or First Relapsed Acute Myeloid Leukemia. An IPC-DATAML-MSKCC Retrospective Study.

Cassandre Petit, Jules Higue, Ziyad Acheaibi

|Feb 06, 2025
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Adriano Venditti, Raffaele Palmieri, Luca Maurillo

|Sep 20, 2024
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis.

Anne-Charlotte Le Floch, Caroline Imbert, Nicolas Boucherit

|Sep 12, 2024
Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study.

Florence Rabian, Sylvie Chevret, Bérengère Gruson

Pageof 5

Frequent Collaborators

7 joint publications

Christian Récher

5 joint publications

Sylvain Garciaz

4 joint publications

Sarah Bertoli

4 joint publications

Raynier Devillier